Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Essure (Model ESS310) Placement Rate Study

ClinicalTrials.gov ID: NCT02064413

Public ClinicalTrials.gov record NCT02064413. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 8:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, United States Clinical Study to Evaluate Placement Success of the ESS310 Essure® System

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and successful placement rate of Essure Model ESS310 device and any factors that may influence the successful placement rate of this device.

Study identification

NCT ID
NCT02064413
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
134 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
21 Years to 44 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2014
Primary completion
Oct 1, 2014
Completion
Nov 25, 2014
Last update posted
Apr 7, 2021

2014

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Not listed Glendale Arizona 85304
Not listed Phoenix Arizona 85015
Not listed Colorado Springs Colorado 80923
Not listed Augusta Georgia 30909
Not listed Fort Wayne Indiana 46825
Not listed Newburgh Indiana 47630
Not listed Grand Blanc Michigan 48439
Not listed Saginaw Michigan 48604
Wayne State University Physicians Group Southfield Michigan 48034
Mayo Clinic - Rochester Rochester Minnesota 55905
Not listed Winston-Salem North Carolina 27103
Not listed Dayton Ohio 45409-2793
Tennessee Women's Care, PC Nashville Tennessee 37205
Vanderbilt University Medical Center Nashville Tennessee 37232
Not listed Fort Worth Texas 76104
Not listed Houston Texas 77074

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Contraception trials

Other public records listing Contraception. Sorted by last update posted; newest first. Not a recommendation.

All Contraception trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02064413, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02064413 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →